Brilacidin tetrahydrochloride
Modify Date: 2024-01-03 18:10:07
Brilacidin tetrahydrochloride structure
|
Common Name | Brilacidin tetrahydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1224095-99-1 | Molecular Weight | 1082.75000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C40H54Cl4F6N14O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Brilacidin tetrahydrochlorideBrilacidin tetrahydrochloride (PMX 30063 tetrahydrochloride) is an anti-infective antimicrobial with MIC90s of 1 and 8 μg/mL for Gram-positive bacteria Streptococcus pneumonia and Streptococcus viridans, and MIC90 of 8 and 4 μg/mL for Gram-negative bacteria Haemophilus influenza and Pseudomonas aeruginosa. Brilacidin tetrahydrochloride is a defensin mimetic antibiotic compound[1][2]. |
| Name | 4-N,6-N-bis[3-[5-(diaminomethylideneamino)pentanoylamino]-2-[(3R)-pyrrolidin-3-yl]oxy-5-(trifluoromethyl)phenyl]pyrimidine-4,6-dicarboxamide,tetrahydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Brilacidin tetrahydrochloride (PMX 30063 tetrahydrochloride) is an anti-infective antimicrobial with MIC90s of 1 and 8 μg/mL for Gram-positive bacteria Streptococcus pneumonia and Streptococcus viridans, and MIC90 of 8 and 4 μg/mL for Gram-negative bacteria Haemophilus influenza and Pseudomonas aeruginosa. Brilacidin tetrahydrochloride is a defensin mimetic antibiotic compound[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Both Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) have the lowest minimum inhibitory concentrations among the bacterial groups. The MIC90s to Brilacidin for Streptococcus pneumonia (SP), Streptococcus viridians (SV), Moraxella (MS), Haemophilus influenza (HI), Pseudomonas aeruginosa (PA), and Serratia marcescens (SM) are 4, 32, 256, 32, 16, and 128-fold higher, respectively, than SA and SE. Brilacidin has Gram-positive in vitro activity; topical Brilacidin 0.5% is minimally irritating; and Brilacidin 0.5% was equally efficacious as Vancomycin (VAN) in a methicillin-resistant S. aureus (MRSA) keratitis model when the corneal epithelium is removed. Brilacidin acts primarily on the bacterial cell membrane by depolarization. Brilacidin is more potent for Gram-positive bacteria (except SV) than Gram-negative bacteria[2]. |
| In Vivo | Brilacidin demonstrates dose-dependent ocular toxicity after 7 topical instillations (every 30 min for 3 h) in the NZW rabbit ocular toxicity model. Brilacidin 1% is determined to be Mildly Irritating (23.0), Brilacidin 0.5% (6.5), and Brilacidin 0.25% (4.0) are determined to be Minimally Irritating, while Brilacidin 0.1% (2.0) and TBS (1.0) are determined to be Practically Nonirritating and 0.01% Brilacidin (0.5) is determined to be Nonirritating based on their Maximum mean total scores (MMTS) values[2]. |
| References |
| Molecular Formula | C40H54Cl4F6N14O6 |
|---|---|
| Molecular Weight | 1082.75000 |
| Exact Mass | 1080.30000 |
| PSA | 318.97000 |
| LogP | 11.68740 |
| Brilacidin tetrahydrochloride |
| UNII-CM3HYX69SK |
| Brilacidin tetrahydrochloride (USAN) |